LI
Liminatus Pharma, Inc. Warrants
LIMNW · NASDAQ
$0.05 +0.00% (+$0.00)
1M -13.48%
Market Cap $1.31M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
46 /100
Fair P/B 4.36x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 225.12%
Asset turnover 0.00x
ROA 367.93%
Debt
10 /100
High Debt/Equity 4.80x
Int. coverage -164.56x
Current ratio 1.12x
Stability
37 /100
Moderate Beta 0.74x
Profitable years 0
EPS volatility 79.63%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na LIMNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chris Kim
Employees
1
Headquarters
Cerritos